Dexcom (DXCM) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $87.71, +5.08% vs the prior close of $83.47.
- Volume 4.79M shares, 1.2x its 50-day average.
- New SEC filings: 144 (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
DXCM jumps 5.1% to $87.71. Closed at $87.71, +5.08% vs the prior close of $83.47. Day range $85.25–$87.88, opened at $85.48.
DXCM daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — DXCM jumps 5.1% to $87.71
- Closed at $87.71, +5.08% vs the prior close of $83.47. Day range $85.25–$87.88, opened at $85.48.
- Volume was 4.79M shares, 1.2x its 50-day average of 4.09M.
- Price is +0.3% vs its 50-day average ($87.49) and +18.7% vs its 200-day average ($73.87).
- 52-week range $54.11–$92.59; today's close sits at 87% of that range, 5.3% below the 52-week high.
Oct 14, 2026 — DXCM dips 1.9% to $83.47
- Closed at $83.47, -1.87% vs the prior close of $85.06. Day range $83.30–$86.18, opened at $85.89.
- Volume was 3.48M shares, 0.8x its 50-day average of 4.14M.
- Price is -4.5% vs its 50-day average ($87.38) and +13.1% vs its 200-day average ($73.77).
- 52-week range $54.11–$92.59; today's close sits at 76% of that range, 9.8% below the 52-week high.
Oct 13, 2026 — DXCM dips 1.0% to $85.06
- Closed at $85.06, -1.00% vs the prior close of $85.92. Day range $84.49–$86.60, opened at $86.19.
- Volume was 4.02M shares, 0.9x its 50-day average of 4.25M.
- Price is -2.7% vs its 50-day average ($87.45) and +15.4% vs its 200-day average ($73.69).
- 52-week range $54.11–$92.59; today's close sits at 80% of that range, 8.1% below the 52-week high.
Oct 12, 2026 — DXCM rises 2.2% to $85.92
- Closed at $85.92, +2.15% vs the prior close of $84.11. Day range $84.21–$86.10, opened at $84.60.
- Volume was 2.99M shares, 0.7x its 50-day average of 4.43M.
- Price is -1.8% vs its 50-day average ($87.50) and +16.7% vs its 200-day average ($73.60).
- 52-week range $54.11–$92.59; today's close sits at 83% of that range, 7.2% below the 52-week high.
Oct 9, 2026 — DXCM dips 0.4% to $84.11
- Closed at $84.11, -0.36% vs the prior close of $84.41. Day range $82.94–$85.49, opened at $84.41.
- Volume was 3.15M shares, 0.7x its 50-day average of 4.48M.
- Price is -3.8% vs its 50-day average ($87.45) and +14.4% vs its 200-day average ($73.51).
- 52-week range $54.11–$92.59; today's close sits at 78% of that range, 9.2% below the 52-week high.
Oct 8, 2026 — DXCM ends flat (+0.1%) to $84.41
- Closed at $84.41, +0.13% vs the prior close of $84.30. Day range $83.08–$84.54, opened at $84.01.
- Volume was 3.61M shares, 0.8x its 50-day average of 4.53M.
- Price is -3.3% vs its 50-day average ($87.26) and +15.0% vs its 200-day average ($73.42).
- 52-week range $54.11–$92.59; today's close sits at 79% of that range, 8.8% below the 52-week high.
Oct 7, 2026 — DXCM rises 1.1% to $84.30
- Closed at $84.30, +1.09% vs the prior close of $83.39. Day range $83.74–$85.70, opened at $83.81.
- Volume was 2.86M shares, 0.6x its 50-day average of 4.56M.
- Price is -3.2% vs its 50-day average ($87.07) and +15.0% vs its 200-day average ($73.33).
- 52-week range $54.11–$92.59; today's close sits at 78% of that range, 9.0% below the 52-week high.
Oct 6, 2026 — DXCM slides 4.0% to $83.39
- Closed at $83.39, -4.04% vs the prior close of $86.90. Day range $82.86–$86.75, opened at $86.28.
- Volume was 3.57M shares, 0.8x its 50-day average of 4.58M.
- Price is -4.0% vs its 50-day average ($86.88) and +13.9% vs its 200-day average ($73.24).
- 52-week range $54.11–$92.59; today's close sits at 76% of that range, 9.9% below the 52-week high.
Oct 5, 2026 — DXCM rises 1.8% to $86.90
- Closed at $86.90, +1.80% vs the prior close of $85.36. Day range $84.75–$87.12, opened at $84.75.
- Volume was 3.08M shares, 0.7x its 50-day average of 4.58M.
- Price is +0.3% vs its 50-day average ($86.68) and +18.8% vs its 200-day average ($73.15).
- 52-week range $54.11–$92.59; today's close sits at 85% of that range, 6.1% below the 52-week high.
Oct 2, 2026 — DXCM dips 1.0% to $85.36, 4 down days in a row
- Closed at $85.36, -1.01% vs the prior close of $86.23. Day range $84.80–$86.67, opened at $86.67.
- Volume was 2.20M shares, 0.5x its 50-day average of 4.60M — lighter than usual.
- Price is -1.2% vs its 50-day average ($86.38) and +16.9% vs its 200-day average ($73.05).
- 52-week range $54.11–$92.59; today's close sits at 81% of that range, 7.8% below the 52-week high.
- That makes 4 straight losses.
DXCM latest news & SEC filings
Every SEC filing by or about DXCM in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 30, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Stern Sadie sold 2,565 shares at $86.15 (≈$220.97K) on Sep 28, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 16, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Augustinos Nicholas sold 6,539 shares at $84.04 (≈$549.54K) on Sep 15, 2026
- Augustinos Nicholas sold 1,550 shares at $84.02 (≈$130.23K) on Sep 14, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 16, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Brown Michael Jon sold 1,700 shares at $84.04 (≈$142.87K) on Sep 15, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 15, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 14, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 10, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 30, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $1.31B (prior year $1.16B) (+13.1% vs Jun 30, 2025)
- Net income: $249.10M (prior year $179.80M) (+38.5% vs Jun 30, 2025)
- Diluted EPS: $0.64 (prior year $0.45) (+42.2% vs Jun 30, 2025)
Jul 30, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade DXCM
- Last results release: Jul 30, 2026 (8-K Item 2.02). Previous ones: Apr 30, 2026, Feb 12, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Oct 29, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.23% (largest 5.1%).
- Liquidity: about 3.99M shares (≈$350.34M) trade per day on average.
- 52-week position: $87.71 vs a range of $54.11–$92.59 (87% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Sadie Stern sold 2,565 shares on Sep 28, 2026.
- Latest filings: 8-K Sep 14, 2026; 8-K Sep 10, 2026; 10-Q Jul 30, 2026.
- Share count: 377.36M shares outstanding (Jul 23, 2026), -3.8% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
DXCM market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 85.48 | 87.88 | 85.25 | 87.71 | 4.79M |
| Oct 14, 2026 | 85.89 | 86.18 | 83.30 | 83.47 | 3.48M |
| Oct 13, 2026 | 86.19 | 86.60 | 84.49 | 85.06 | 4.02M |
| Oct 12, 2026 | 84.60 | 86.10 | 84.21 | 85.92 | 2.99M |
| Oct 9, 2026 | 84.41 | 85.49 | 82.94 | 84.11 | 3.15M |
| Oct 8, 2026 | 84.01 | 84.54 | 83.08 | 84.41 | 3.61M |
| Oct 7, 2026 | 83.81 | 85.70 | 83.74 | 84.30 | 2.86M |
| Oct 6, 2026 | 86.28 | 86.75 | 82.86 | 83.39 | 3.57M |
| Oct 5, 2026 | 84.75 | 87.12 | 84.75 | 86.90 | 3.08M |
| Oct 2, 2026 | 86.67 | 86.67 | 84.80 | 85.36 | 2.20M |
| Oct 1, 2026 | 86.46 | 87.70 | 85.81 | 86.23 | 3.03M |
| Sep 30, 2026 | 86.21 | 86.75 | 85.26 | 86.29 | 3.47M |
| Sep 29, 2026 | 86.63 | 87.03 | 85.24 | 86.64 | 3.12M |
| Sep 28, 2026 | 86.87 | 87.34 | 85.27 | 86.68 | 3.41M |
| Sep 25, 2026 | 87.38 | 87.64 | 86.36 | 86.62 | 1.89M |
| Sep 24, 2026 | 87.68 | 88.00 | 86.88 | 87.47 | 2.14M |
| Sep 23, 2026 | 89.50 | 90.05 | 87.36 | 87.73 | 3.67M |
| Sep 22, 2026 | 89.12 | 90.39 | 88.18 | 89.53 | 7.30M |
| Sep 21, 2026 | 88.83 | 89.68 | 88.33 | 89.17 | 3.52M |
| Sep 18, 2026 | 87.83 | 89.92 | 87.39 | 89.35 | 14.57M |
About Dexcom
Dexcom (DXCM) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in SAN DIEGO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1093557.
DXCM board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Steven R Altman | Director | Jun 1, 2026 |
| Nicholas Augustinos | Director | Sep 16, 2026 |
| Euan A. Ashley | Director | Jun 1, 2026 |
| Glenn S Boehnlein | Director | Sep 10, 2026 |
| Richard Alexander Collins | Director | Jun 1, 2026 |
| Rimma Driscoll | Director | Jun 1, 2026 |
| Mark G Foletta | Director | Aug 4, 2026 |
| Renee D Gala | Director | Jun 1, 2026 |
| Bridgette P Heller | Director | Aug 13, 2026 |
| Jacob Steven Leach | President, CEO, and Director | Aug 25, 2026 |
| Kyle Malady | Director | Jun 1, 2026 |
| Albert Frederick Iv Osterloh | Director | Jun 1, 2026 |
| Kevin R Sayer | Executive Chair | Aug 24, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Michael Jon Brown | EVP Chief Legal Compliance Off | Sep 16, 2026 |
| Jon Coleman | EVP, Chief Commercial Officer | Jun 5, 2026 |
| Jacob Steven Leach | President, CEO, and Director | Aug 25, 2026 |
| Kevin R Sayer | Executive Chair | Aug 24, 2026 |
| Sadie Stern | EVP Chief People & Culture Off | Sep 30, 2026 |
| Jereme M Sylvain | EVP, Chief Financal Officer | Sep 14, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 28, 2026 | Sadie Stern | Sale | 2,565 | $86.15 |
| Sep 15, 2026 | Nicholas Augustinos | Sale | 6,539 | $84.04 |
| Sep 15, 2026 | Michael Jon Brown | Sale | 1,700 | $84.04 |
| Sep 14, 2026 | Nicholas Augustinos | Sale | 1,550 | $84.02 |
| Sep 10, 2026 | Jereme M Sylvain | Sale | 3,638 | $83.27 |
| Aug 27, 2026 | Sadie Stern | Sale | 2,565 | $88.37 |
| Aug 20, 2026 | Kevin R Sayer | Sale | 19,308 | $89.71 |
| Aug 20, 2026 | Kevin R Sayer | Sale | 7,351 | $90.78 |
| Aug 20, 2026 | Kevin R Sayer | Sale | 97 | $91.41 |
| Aug 14, 2026 | Michael Jon Brown | Sale | 1,700 | $91.93 |
| Aug 12, 2026 | Bridgette P Heller | Sale | 1,012 | $88.29 |
| Aug 3, 2026 | Mark G Foletta | Sale | 2,000 | $85.32 |
| Jul 31, 2026 | Mark G Foletta | Sale | 2,000 | $80.00 |
| Jul 20, 2026 | Kevin R Sayer | Sale | 26,756 | $76.32 |
| Jul 15, 2026 | Michael Jon Brown | Sale | 1,700 | $74.42 |
DXCM financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $4.66B | $836.30M | 2.09 | $1.44B |
| Dec 31, 2024 | $4.03B | $576.20M | 1.42 | $989.50M |
| Dec 31, 2023 | $3.62B | $541.50M | 1.30 | $748.50M |
| Dec 31, 2022 | $2.91B | $341.20M | 0.82 | $669.50M |
| Dec 31, 2021 | $2.45B | $216.90M | 0.53 | $442.50M |
Latest balance sheet: total assets $6.46B, total liabilities $3.83B, cash $1.10B (as of Jun 30, 2026).
DXCM earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 30, 2026 | 8-K Item 2.02 (results) | $74.54 |
| Apr 30, 2026 | 8-K Item 2.02 (results) | $59.55 |
| Feb 12, 2026 | 8-K Item 2.02 (results) | $65.08 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $70.98 |
| Oct 30, 2025 | 8-K Item 2.02 (results) | $68.20 |
| Jul 30, 2025 | 8-K Item 2.02 (results) | $89.06 |
| May 1, 2025 | 8-K Item 2.02 (results) | $70.26 |
| Feb 13, 2025 | 8-K Item 2.02 (results) | $84.09 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $79.84 |
| Oct 24, 2024 | 8-K Item 2.02 (results) | $74.85 |
| Jul 25, 2024 | 8-K Item 2.02 (results) | — |
| Apr 25, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)Globus Medical (GMED)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on DXCM
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.